Currently, there are 135.72M common shares owned by the public and among those 130.44M shares have been available to trade.
The company’s stock has a 5-day price change of -11.64% and -17.19% over the past three months. ENPH shares are trading -30.35% year to date (YTD), with the 12-month market performance down to -25.66% lower. It has a 12-month low price of $73.49 and touched a high of $141.63 over the same period. ENPH has an average intraday trading volume of 2.88 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -15.65%, -17.62%, and -19.55% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Enphase Energy Inc (NASDAQ: ENPH) shares accounts for 85.03% of the company’s 135.72M shares outstanding.
It has a market capitalization of $12.46B and a beta (3y monthly) value of 1.72. The stock’s trailing 12-month PE ratio is 100.59, while the earnings-per-share (ttm) stands at $0.92. The company has a PEG of 4.02 and a Quick Ratio of 3.90 with the debt-to-equity ratio at 1.49. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.82% over the week and 4.49% over the month.
Earnings per share for the fiscal year are expected to decrease by -42.97%, and 85.25% over the next financial year.
Looking at the support for the ENPH, a number of firms have released research notes about the stock. RBC Capital Mkts stated their Sector Perform rating for the stock in a research note on Oct-16-24, with the firm’s price target at $125-$100. Exane BNP Paribas was of a view on August 07, 2024 that the stock is Outperform, while Canaccord Genuity gave the stock Buy rating on July 24, 2024, issuing a price target of $150- $140. HSBC Securities on their part issued Buy rating on June 10, 2024.
